NCT00550615 Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00550017 A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) Status TERMINATED Phase PHASE1/PHASE2
NCT00546780 A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse Status COMPLETED Phase PHASE3
NCT00546715 A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT00546247 A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) Status TERMINATED Phase PHASE1/PHASE2
NCT00534807 A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer Status WITHDRAWN Phase PHASE1
NCT00534313 Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis Status TERMINATED Phase PHASE2
NCT00529763 Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects Status COMPLETED Phase PHASE2
NCT00529178 Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease Status COMPLETED Phase PHASE4
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3